Share Twitter LinkedIn Facebook Email Susan Demo, Ph.D Calithera Biosciences discusses Only 3% Of Cancer Patients Participate In Clinical Trials at Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on September 22, 2018